Methods of using and compositions comprising immunomudulatory compounds for the treatment and management of myeloproliferative diseases

Details for Australian Patent Application No. 2003241289 (hide)

International Classifications

Event Publications

11 September 2003 Complete Application Filed

Priority application(s): 60/424,730 06.11.02 US

8 July 2004 Application Open to Public Inspection

Published as AU-B-2003241289

3 January 2008 Application Accepted

Published as AU-B-2003241289

17 April 2008 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 20 Mar 2008. Address for service in Australia - Phillips Ormonde & Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000

15 May 2008 Standard Patent Sealed

11 September 2008 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 20 Mar 2008 2004

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.